Redcare Pharmacy stock pre-market at EUR 70.50: minus 0.07 percent
Published on 10/14/2026 at 08:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSDates And Trading Levels
- Redcare Pharmacy’s next scheduled quarterly statement is October 29, 2026.
- Redcare Pharmacy stock trades pre-market at EUR 70.50 at 8:13 a.m. CEST at Lang & Schwarz on October 14, 2026, 0.07 percent below the Xetra close of October 13, 2026.
- A round-number level of EUR 71.00 is 0.71 percent above the pre-market price.
Redcare Pharmacy stock trades at EUR 70.50 pre-market at Lang & Schwarz at 8:13 a.m. CEST on October 14, 2026. That is 0.07 percent below the Xetra close of October 13, 2026, at EUR 70.55. The bid is EUR 70.05 and the ask is EUR 70.95. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Redcare Pharmacy stock.
What matters today
Redcare Pharmacy’s next scheduled quarterly statement is October 29, 2026, according to the company’s investor-relations announcement. The next round-number level is EUR 71.00, which is 0.71 percent above the pre-market price. The bid-ask spread is EUR 0.90, based on the quoted EUR 70.05 bid and EUR 70.95 ask.
The company’s investor-relations release said the third-quarter interim statement and quarterly conference call are scheduled for October 29, 2026. The same announcement identified Redcare Pharmacy N.V. as the issuer and said the company is part of the SDAX. The release was disseminated by EQS News on September 28, 2026.
Market context: Market report SDAX.
